Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Depressive Disorder, Major

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Depressive Disorder, Major in 5 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schijven, D1
Sousa, VC1
Roelofs, J1
Olivier, B1
Olivier, JD1
Underwood, MD1
Kassir, SA1
Bakalian, MJ1
Galfalvy, H1
Mann, JJ2
Arango, V2
Scorza, MC1
Lladó-Pelfort, L1
Oller, S1
Cortés, R1
Puigdemont, D1
Portella, MJ1
Pérez-Egea, R1
Alvarez, E1
Celada, P1
Pérez, V1
Artigas, F1
Mizrahi, C1
Stojanovic, A1
Urbina, M1
Carreira, I1
Lima, L1
Huang, YY1
Battistuzzi, C1
Oquendo, MA1
Harkavy-Friedman, J1
Greenhill, L1
Zalsman, G1
Brodsky, B1
Brent, DA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Fluoxetine Versus Fluoxetine Plus DU125530 in Latency of Antidepressant Response Shortening in Major Depressive Disorder[NCT01119430]Phase 250 participants (Actual)Interventional2004-05-31Terminated (stopped due to interim analysis suggested no differences with whole sample)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for 8-hydroxy-2-(di-n-propylamino)tetralin and Depressive Disorder, Major

ArticleYear
Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.
    British journal of pharmacology, 2012, Volume: 167, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Animals; Antidepressive Agents; Brain; Depressive Dis

2012

Other Studies

4 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Depressive Disorder, Major

ArticleYear
Serotonin 1A receptors and sexual behavior in a genetic model of depression.
    Pharmacology, biochemistry, and behavior, 2014, Volume: 121

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Depressive Disorder, Major; Disease Models,

2014
Neuron density and serotonin receptor binding in prefrontal cortex in suicide.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adolescent; Adult; Aged; Autoradiography; Case-Control Studi

2012
Differential cAMP levels and serotonin effects in blood peripheral mononuclear cells and lymphocytes from major depression patients.
    International immunopharmacology, 2004, Volume: 4, Issue:8

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Colforsin; Cyclic AMP; Depressive Disorder, Major; Fe

2004
Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Alleles; Anxiety Disorders; Autoradiography; Depressi

2004